Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

NCT03871816 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT03871816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03871816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
April 22, 2019
Completion date
November 22, 2022
Enrollment
14,532 (actual)
Sites
338

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer